FGF9 and metabolic dysfunction-associated steatohepatitis: It has been reported that FGF9 is a critical regulator of organ development.[14, 15] In addition, the oncogenic roles of FGF9 in tumors have been characterized in previous studies.[16, 17, 18] However, the contribution of FGF9 to NASH‐driven HCC remains unclear.